United States · Series A startup

Who invested in NILO Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$101Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $101MOct 2025
Investors
3
See who backed them

The rounds

  1. Oct 2025

Everyone who backed them

Lux CapitalVC firm1round
DCVCVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NILO Therapeutics

Who invested in NILO Therapeutics?

NILO Therapeutics's investors include Lux Capital, DCVC and Alexandria Venture Investments.

How much has NILO Therapeutics raised?

NILO Therapeutics has raised $101M across 1 round since 2025.

When did NILO Therapeutics last raise?

NILO Therapeutics's most recent round was a Series A of $101M in Oct 2025.

What was NILO Therapeutics's biggest round?

Its most recent round, $101M in Oct 2025, is also its largest on record.

Who backed NILO Therapeutics first?

NILO Therapeutics's first round on record, in Oct 2025, was backed by Lux Capital, DCVC and Alexandria Venture Investments.

What stage is NILO Therapeutics at?

NILO Therapeutics's latest named round is a Series A, in Oct 2025.

Where is NILO Therapeutics based?

NILO Therapeutics is based in the United States.

Companies like NILO Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.